Market Tracker

07/26 2:48pm ET

Exact Sciences Corp (NASDAQ:EXAS)

40.33
BATS BZX Real-Time Price
As of 2:47pm ET
 +3.00 / +8.04%
Today’s Change
13.05
Today|||52-Week Range
42.17
+201.87%
Year-to-Date
Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?
Jul 21 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 17th
Jul 17 / Zacks.com - Paid Partner Content
Why Exact Sciences (EXAS) Might Surprise This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Bio...
Jul 12 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 19th
Jul 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close37.33
Today’s open39.65
Day’s range39.55 - 42.17
Volume317,785
Average volume (3 months)3,097,914
Market cap$4.4B
Dividend yield--
Data as of 2:47pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)+4.68%
Earnings growth (this year)+18.98%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+151.99%
P/E ratioNM
Price/Sales13.76
Price/Book12.27

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-1.11-0.94%
BLUEbluebird bio Inc-0.15-0.15%
NBIXNeurocrine Bioscienc...+0.03+0.06%
NKTRNektar Therapeutics-0.14-0.60%
Data as of 2:48pm ET, 07/26/2017

Financials

Last reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$99.4M
Annual profit (last year)-$167.2M
Net profit margin-168.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts